Member Info for Matml74

Plenty of big late trades reported again. Another tr1 next week. Hope everyone loaded up again today.

I think the daily pattern we have had over the past week will change tomorrow. I am expecting a fast start after the todays TR1, however if there is a dip early everyone who can top up should be doing so IMO. I will be averaging up for sure if it does drop or hold at this level.

They have a decent stake in Bio Rad Labs (Macao 14 billion).

And this is what’s on their website:

“Bio-Rad is ISO-certified with cGMP facilities set up to ensure our products meet the stringent requirements of regulatory agencies. We have experience working directly with the FDA and regularly assist our customers with audit requirements. We offer solutions that are customizable to fit perfectly with your needs in drug discovery, development, and manufacturing.”

Threshold was crossed on the 1st and big buying has continued. Exciting times ahead!

Seems to me the price is controlled by the MM's at the moment. The daily pattern is very consistent. Drop in the first hour collecting shares, hold price to 3/4pm, print 200k - 500k buys just above the ask. Here's hoping its a prelude to a big rise on news.

Steady.... Surely if they were sells price would be on downward trend? Would like to see some TR1's to confirm though.

Tiny volume today so no issues. Lets hope the Beckman news hits next week and gets share moving.

Retireby40 Thanks for sharing. So confirmation at the end of further large scale international trials!!

Why would they tech transfer "immediately" if BBI hadn't produced a batch yet and these test will require no further validation? The BBI process has started. ISO13485 accreditation likely already achieved. Everything ready to go apart from CONDOR approval. Hopefully they pull their finger out!

"Technology transfer to Abingdon Health will begin immediately with the aim of manufacturing an equivalent rapid antigen test product which therefore does not require additional clinical validation/regulatory approvals. "

OK sorry missed that bit. I take it all back! Not sure it matters in the long run through.....

Where in that RNS does it state they have not started clinical validation? Nowhere. Obvious deramp. Filtered.

Correct Mr Big

That was any easy filter job!

Hopefully see EUA alongside of this trial extension

Sell up I will take your shares.

Brilliant CW25!

Thread should be deleted!

I agree. Must happen soon. Be interesting to see who has been buying and also who the seller is.

Exactly Chris. I don’t really care if it’s this week or next as we know they are coming at some point in the near future. I am very curious to see them though and would be very surprised if they don’t support the findings of the previous trial results in asthma and Covid. GL

Chris, my interpretation is that it probably includes the COPD numbers as well as those from the asthma trial. But it is obvious from his comments that they felt that they had sufficient data to back the drugs safety/tolerability etc to support regulatory approval if the trial was successful in IMO.

Richard’s Quote is from the following article back in March.

https://pharmafield.co.uk/pharma_news/synairgen-to-start-trial-of-sng001-in-covid-19